Lebanon
“Do we have a future?”- One year after the Beirut explosion, the situation is much worse
Latest News - 4 Aug 2021
Vaccination
Opposing countries must stop filibustering negotiations on ‘TRIPS Waiver’ at WTO
Since the "TRIPS Waiver", a landmark proposal to waive intellectual property (IP) on lifesaving COVID-19 drugs, diagnostics and vaccines, was first tabled nearly 10 months ago, the pandemic has worsened in many countries across Africa, Latin America and Asia. Press Release - 26 Jul 2021
South Africa
Supporting overstretched health centres and vulnerable communities in the aftermath of the violence
Latest News - 22 Jul 2021
HIV/Aids
Access to affordable liposomal amphotericin B (L-AmB) crucial to ending cryptococcal meningitis deaths
Access to affordable liposomal amphotericin B (L-AmB) crucial to ending cryptococcal meningitis deaths by 2030 Press Release - 21 Jul 2021
Maternal health
Sierra Leone: Living through epidemics and expanding in challenging times
MSF has been working in the Kenema district in eastern Sierra Leone since 2019 to provide medical support to people who are excluded from access to health care. During the last 3 years, MSF provided medical care to thousands of patients in the area and ensured uninterrupted provision of life-saving care to people, even when COVID-19 imposed challenges. Patient and Staff Stories - 15 Jul 2021
Access to Healthcare
Urgently safeguard people’s access to healthcare, healthcare workers and medical supplies as social unrest deepens in South Africa
Press Release - 14 Jul 2021
Syria
Northwest Syria: Millions of people rely on humanitarian aid to survive
Around 4 million people are estimated to live in northwest Syria. Of that number, the UN estimates that at least 3 million require some form of humanitarian aid. The 10 years of conflict, the COVID-19 pandemic and a severe economic crisis have further aggravated people’s vulnerability and their reliance on humanitarian aid in the region. Patient and Staff Stories - 8 Jul 2021
Coronavirus COVID-19 pandemic
Second most recommended drug for COVID-19, will remain unaffordable & inaccessible for many
Press Release - 7 Jul 2021
Coronavirus COVID-19 pandemic
